Personalized biological treatment with lanadelumab in a patient with recurrent attacks of hereditary angioedema
Hereditary angioedema (HAE) is an autosomal dominantly inherited disease caused by deficiency of C1 esterase inhibitor protein type 1 (about 85% of patients with HAE-C1-INH) or type 2 oedema (about 15% of patients with HAE-C1-INH) by C1 inhibitor dysfunction, with normal serum levels (HAE-2). Long-t...
Saved in:
Main Authors: | Artur Gęsicki, Maciej F. Kozlowski, Karolina Żurawska, Weronika Ossowska, Jakub Sikora, Szymon Dyguś, Iwona Poziomkowska-Gęsicka |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2024-08-01
|
Series: | Alergologia Polska |
Subjects: | |
Online Access: | https://www.termedia.pl/Personalized-biological-treatment-with-lanadelumab-in-a-patient-with-recurrent-attacks-of-hereditary-angioedema,123,54687,1,1.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The latest therapeutic reports on short-term and long-term prophylaxis in the treatment of hereditary angioedema
by: Maciej Kozłowski, et al.
Published: (2024-02-01) -
Investigation of the correlation of C1 esterase inhibitor
levels and functions with attack severity and frequency
in hereditary angioedema
by: Fatma Arzu Akkuş, et al.
Published: (2024-06-01) -
Indirect treatment comparison of lanadelumab and a C1-esterase inhibitor in pediatric patients with hereditary angioedema
by: Maureen Watt, et al.
Published: (2025-01-01) -
Abdominal attack in a patient with hereditary angioedema due to C1 inhibitor deficiency complicated by a perforated peptic ulcer
by: Piotr Obtulowicz, et al.
Published: (2024-02-01) -
Awareness of hereditary angioedema among emergency
physicians: a survey study
by: Recep Evcen, et al.
Published: (2024-02-01)